BAYER AG
Acción · DE000BAY0017 · BAY001 (XFRA)
26,61 EUR
06.06.2025 19:47
Cotizaciones actuales de BAYER AG
Bolsa | Ticker | Moneda | Última operación | Precio | Variación diaria |
---|---|---|---|---|---|
![]() XETRA |
BAYN.DE
|
EUR
|
06.06.2025 15:35
|
26,44 EUR
| 26,43 EUR
+0,02 %
|
Rendimiento
Día | Semana | Mes | 3 meses | 6 meses | 1 año | 5 años |
---|---|---|---|---|---|---|
0,00 % | 7,54 % | 10,70 % | 7,11 % | 33,02 % | -5,22 % | -59,75 % |
Perfil de la empresa para BAYER AG Acción
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines, medical products, medicated skincare products, nutritional supplements, and self-care solutions in dermatology, nutritional supplements, pain and cardiovascular risk prevention, digestive health, allergy, and cold and cough. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solution, and pest and weed control products, as well as customer service for agriculture. This segment also provides breeding, propagation, and production/processing of seeds, including seed dressing. The company has a collaboration agreement with MD Anderson Cancer Center to develop oncology drugs; research and license agreement with Dewpoint Therapeutics, Inc. for the development of new treatments for cardiovascular and gynecological diseases; collaboration agreement with Exscientia Ltd, Foundation Medicine Inc., and Evotec AG; research collaboration with Arvinas Inc.; strategic research partnership with University of Oxford to develop novel gynecological therapies; and Kyoto University to identify new drugs candidates for the treatment of pulmonary diseases. It distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft was founded in 1863 and is headquartered in Leverkusen, Germany.
Fondos invertidos
Los siguientes fondos han invertido en: BAYER AG invertido:
Fondo | Vol. en millones 42.689,80 | Porcentaje (%) 8,40 % |
Fondo | Vol. en millones 59,63 | Porcentaje (%) 3,82 % |
Fondo | Vol. en millones 1.314,48 | Porcentaje (%) 3,43 % |
Fondo | Vol. en millones 1.447,69 | Porcentaje (%) 3,32 % |
Fondo | Vol. en millones 1.043,15 | Porcentaje (%) 1,68 % |
Datos de la empresa
Nombre BAYER AG
Empresa Bayer AG
Sitio web
https://www.bayer.com
Mercado principal
Frankfurt

WKN BAY001
ISIN DE000BAY0017
Tipo de valor Acción
Sector Healthcare
Industria Drug Manufacturers - General
CEO Mr. William N. Anderson
Capitalización de mercado 21 Mrd.
País Alemania
Moneda EUR
Empleados 90,6 T
Dirección Kaiser-Wilhelm-Allee 1, 51368 Leverkusen
Fecha de OPV 1996-12-16
Dividendos de 'BAYER AG'
Fecha ex-dividendo | Dividendo por acción |
---|---|
28.04.2025 | 0,11 EUR |
29.04.2024 | 0,11 EUR |
02.05.2023 | 2,40 EUR |
02.05.2022 | 2,00 EUR |
28.04.2021 | 2,00 EUR |
29.04.2020 | 2,80 EUR |
29.04.2019 | 2,80 EUR |
28.05.2018 | 2,80 EUR |
02.05.2017 | 2,70 EUR |
28.04.2017 | 2,70 EUR |
Símbolos de cotización
Nombre | Símbolo |
---|---|
Frankfurt | BAYN.F |
XETRA | BAYN.DE |
Otras acciones
Los inversores que tienen BAYER AG también tienen las siguientes acciones en su cartera:
La plataforma financiera MoneyPeak rastrea y analiza inversiones y carteras.
Desde depósitos de valores hasta compras de criptomonedas.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.
Útil, simple y gratuito. Acciones, ETF, ETC, ETN, índices, fondos, bonos, certificados, divisas, opciones, derechos de suscripción.